Short Reads | GenomeWeb

Short Reads

Premium

It was a sad finale to a brilliant career. James Watson, whose reputation for saying shocking things was second only to his reputation as a Nobel Prize winner, retired late last year from his position as chancellor of Cold Spring Harbor Laboratory after making a series of inflammatory comments about black people being genetically inferior. Watson’s ongoing book tour was abruptly canceled, and Cold Spring Harbor’s board of trustees suspended him for the remarks. Days later, Watson announced his retirement from the institution where he had worked for more than 40 years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.